<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Whitehead Gibbons | Activity</title>
	<link>https://www.catswannabecats.com/members/wallash4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/wallash4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Whitehead Gibbons.</description>
	<lastBuildDate>Fri, 19 Jun 2026 15:42:02 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">dde3db95d813a39e4e118e2b3fe8f1ee</guid>
				<title>Whitehead Gibbons posted an update: The ability to detect low concentrations of biomarkers in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25953/</link>
				<pubDate>Mon, 09 Jun 2025 12:29:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>The ability to detect low concentrations of biomarkers in patient samples is one of the cornerstones of modern healthcare. In general, biosensing approaches are based on measuring signals resulting from the interaction of a large ensemble of molecules with the sensor. Here, we report a biosensor platform using DNA origami featuring a central&hellip;<span class="activity-read-more" id="activity-read-more-25953"><a href="https://www.catswannabecats.com/activity/p/25953/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b12dae22efcf0a035ad2e35a6df9f19d</guid>
				<title>Whitehead Gibbons posted an update: ers for the first-tier assay was 67%, with a false-positive [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24515/</link>
				<pubDate>Sun, 08 Jun 2025 12:52:22 -0400</pubDate>

									<content:encoded><![CDATA[<p>ers for the first-tier assay was 67%, with a false-positive rate of 0.0057%. Conclusions and Relevance This newborn screening pilot study reported results on 2 lysophosphatidylcholine analytes, identifying 3 male infants with X-ALD, 3 X-ALD-heterozygous female infants, and 3 infants with other disorders associated with increased very long-chain&hellip;<span class="activity-read-more" id="activity-read-more-24515"><a href="https://www.catswannabecats.com/activity/p/24515/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">06abf073ce0482565f6f3dcbca068694</guid>
				<title>Whitehead Gibbons posted an update: Vessel damage is a general pathological process in many [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19144/</link>
				<pubDate>Wed, 04 Jun 2025 12:35:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>Vessel damage is a general pathological process in many neurodegenerative disorders, as well as spinal cord injury, stroke, or trauma. Biomaterials can present novel tools to repair and regenerate damaged vessels. The aim of the present study is to test collagen hydrogels loaded with different angiogenic factors to study vessel repair in&hellip;<span class="activity-read-more" id="activity-read-more-19144"><a href="https://www.catswannabecats.com/activity/p/19144/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f295432d15edf904fa88146de4ee60f3</guid>
				<title>Whitehead Gibbons posted an update: Of course, to allow for proper treatment, early and rapid [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7316/</link>
				<pubDate>Sat, 31 May 2025 18:52:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>Of course, to allow for proper treatment, early and rapid diagnosis of TBM must occur. Diagnosis has always been a challenge but the field of TB diagnosis is evolving, with sensitivities of at least 70% now possible in less than two hours with GeneXpert MTB/Rif Ultra. In addition, advanced molecular techniques such as CRISPR-MTB and metagenomic&hellip;<span class="activity-read-more" id="activity-read-more-7316"><a href="https://www.catswannabecats.com/activity/p/7316/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">37be8d4643b2b26d49851a98744be6a1</guid>
				<title>Whitehead Gibbons became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7247/</link>
				<pubDate>Sat, 31 May 2025 18:32:59 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>